Neglected tropical diseases (NTDs) affect more than 1.5 billion of the world’s poorest people, seriously damaging their health and potentially robbing them of educational and economic opportunities. Combating NTDs is one of the most cost-effective interventions in global health today: because of innovative partnerships with pharmaceutical companies, treatment for some of the most common diseases often requires one pill, once a year—at a cost of $.50 per person.
The Shefa Fund has supported the prevention and treatment of intestinal worms among school-children in Ethiopia and Yemen, through mass drug administration.
guidebooks on preventing NTDs produced
children accessed treatment for intestinal worms
teachers and health workers trained on deworming treatment guidelines created by the World Health Organization
The Shefa Fund’s $1 million grant allowed the END Fund and its local partners to reach 7.8 million children in three highly endemic regions of Ethiopia with treatment for intestinal worms. The grant also provided training sessions for government officials, frontline health workers, and teachers on intestinal worm prevention and treatment.
The END Fund, a leader in the prevention and treatment of neglected tropical diseases, works collaboratively with other non-governmental organizations, pharmaceutical companies, leaders from developing countries, and communities to prevent and treat five of the most prevalent NTDs.